These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 33228195)

  • 21. Inhibition of DT-diaphorase (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and flavone-8-acetic acid (FAA): implications for bioreductive drug development.
    Phillips RM
    Biochem Pharmacol; 1999 Jul; 58(2):303-10. PubMed ID: 10423172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Negative Cooperativity in NAD(P)H Quinone Oxidoreductase 1 (NQO1).
    Megarity CF; Abdel-Aal Bettley H; Caraher MC; Scott KA; Whitehead RC; Jowitt TA; Gutierrez A; Bryce RA; Nolan KA; Stratford IJ; Timson DJ
    Chembiochem; 2019 Nov; 20(22):2841-2849. PubMed ID: 31165578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NQO1-activated phenothiazinium redox cyclers for the targeted bioreductive induction of cancer cell apoptosis.
    Wondrak GT
    Free Radic Biol Med; 2007 Jul; 43(2):178-90. PubMed ID: 17603928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity.
    Pink JJ; Planchon SM; Tagliarino C; Varnes ME; Siegel D; Boothman DA
    J Biol Chem; 2000 Feb; 275(8):5416-24. PubMed ID: 10681517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular mechanisms of tirapazamine (SR 4233, Win 59075)-induced hepatocyte toxicity under low oxygen concentrations.
    Khan S; O'Brien PJ
    Br J Cancer; 1995 Apr; 71(4):780-5. PubMed ID: 7710944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative structure-activity relationships in enzymatic single-electron reduction of nitroaromatic explosives: implications for their cytotoxicity.
    Cenas N; Nemeikaite-Ceniene A; Sergediene E; Nivinskas H; Anusevicius Z; Sarlauskas J
    Biochim Biophys Acta; 2001 Sep; 1528(1):31-8. PubMed ID: 11514095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flavoenzyme-catalyzed redox cycling of hydroxylamino- and amino metabolites of 2,4,6-trinitrotoluene: implications for their cytotoxicity.
    Sarlauskas J; Nemeikaite-Ceniene A; Anusevicius Z; Miseviciene L; Julvez MM; Medina M; Gomez-Moreno C; Cenas N
    Arch Biochem Biophys; 2004 May; 425(2):184-92. PubMed ID: 15111126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions of the antioxidant enzymes NAD(P)H: Quinone oxidoreductase 1 (NQO1) and NRH: Quinone oxidoreductase 2 (NQO2) with pharmacological agents, endogenous biochemicals and environmental contaminants.
    Rashid MH; Babu D; Siraki AG
    Chem Biol Interact; 2021 Aug; 345():109574. PubMed ID: 34228969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel plasma membrane quinone reductase and NAD(P)H:quinone oxidoreductase 1 are upregulated by serum withdrawal in human promyelocytic HL-60 cells.
    Forthoffer N; Gómez-Díaz C; Bello RI; Burón MI; Martín SF; Rodríguez-Aguilera JC; Navas P; Villalba JM
    J Bioenerg Biomembr; 2002 Jun; 34(3):209-19. PubMed ID: 12171070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specificity of human aldo-keto reductases, NAD(P)H:quinone oxidoreductase, and carbonyl reductases to redox-cycle polycyclic aromatic hydrocarbon diones and 4-hydroxyequilenin-o-quinone.
    Shultz CA; Quinn AM; Park JH; Harvey RG; Bolton JL; Maser E; Penning TM
    Chem Res Toxicol; 2011 Dec; 24(12):2153-66. PubMed ID: 21910479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA strand scission and free radical production in menadione-treated cells. Correlation with cytotoxicity and role of NADPH quinone acceptor oxidoreductase.
    Nutter LM; Ngo EO; Fisher GR; Gutierrez PL
    J Biol Chem; 1992 Feb; 267(4):2474-9. PubMed ID: 1370822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol.
    Asher G; Dym O; Tsvetkov P; Adler J; Shaul Y
    Biochemistry; 2006 May; 45(20):6372-8. PubMed ID: 16700548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preferential utilization of NADPH as the endogenous electron donor for NAD(P)H:quinone oxidoreductase 1 (NQO1) in intact pulmonary arterial endothelial cells.
    Bongard RD; Lindemer BJ; Krenz GS; Merker MP
    Free Radic Biol Med; 2009 Jan; 46(1):25-32. PubMed ID: 18848878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Naphtho[1',2':4,5]imidazo[1,2-a]pyridine-5,6-diones: Synthesis, enzymatic reduction and cytotoxic activity.
    Šarlauskas J; Pečiukaitytė-Alksnė M; Misevičienė L; Marozienė A; Polmickaitė E; Staniulytė Z; Čėnas N; Anusevičius Ž
    Bioorg Med Chem Lett; 2016 Jan; 26(2):512-517. PubMed ID: 26681508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DT-diaphorase protects cells from the hypoxic cytotoxicity of indoloquinone EO9.
    Plumb JA; Gerritsen M; Workman P
    Br J Cancer; 1994 Dec; 70(6):1136-43. PubMed ID: 7526885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antioxidant response induced by serum withdrawal protects HL-60 cells against inhibition of NAD(P)H:quinone oxidoreductase 1.
    Gómez-Díaz C; Bello RI; López-Lluch G; Forthoffer N; Navas P; Villalba JM
    Biofactors; 2003; 18(1-4):219-28. PubMed ID: 14695937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological inhibitors of NAD(P)H quinone oxidoreductase, NQO1: structure/activity relationships and functional activity in tumour cells.
    Nolan KA; Scott KA; Barnes J; Doncaster J; Whitehead RC; Stratford IJ
    Biochem Pharmacol; 2010 Oct; 80(7):977-81. PubMed ID: 20599803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of NAD(P)H:quinone oxidoreductase (NQO1) in apoptosis induction by aziridinylbenzoquinones RH1 and MeDZQ.
    Nemeikaite-Ceniene A; Dringeliene A; Sarlauskas J; Cenas N
    Acta Biochim Pol; 2005; 52(4):937-41. PubMed ID: 15940348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of NAD(P)H:quinone oxidoreductase in the progression of neuronal cell death in vitro and following cerebral ischaemia in vivo.
    Kapinya KJ; Harms U; Harms C; Blei K; Katchanov J; Dirnagl U; Hörtnagl H
    J Neurochem; 2003 Mar; 84(5):1028-39. PubMed ID: 12603827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxicity of RH1: NAD(P)H:quinone acceptor oxidoreductase (NQO1)-independent oxidative stress and apoptosis induction.
    Tudor G; Alley M; Nelson CM; Huang R; Covell DG; Gutierrez P; Sausville EA
    Anticancer Drugs; 2005 Apr; 16(4):381-91. PubMed ID: 15746574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.